Theres no clinical evidence to advise all people with epilepsy against caffeine, but if you notice it impacting you, discuss it with your neurologist
Plus, there have been no documented interactions with any of the nutrient ingredients in the mentioned products when they are taken simultaneously
Active Ingredient: semaglutide
Thank you Melissa & Trisha
Yes, GLP-1 receptor agonists have demonstrated cardiovascular benefits, such as reducing the risk of heart attack and stroke in individuals with type 2 diabetes and established cardiovascular disease
Because GHK-Cus value comes from sustained, systemic support rather than a one-time concentrated dose, the format thats easiest to use consistently without needles, mixing, or refrigeration is generally the more effective choice in practice